Company · CIK 0001510580 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Kite Pharma, Inc. · KITE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2017 MForm 4 → | Mar 2, 6:08 am EST | David D ChangEVP, R&D, Chief Medical Off. | 60,000 | $6.89 | $413,400 | 110,165 | — | plan? |
| Mar 1, 2017 MForm 4 → | Mar 2, 6:06 am EST | Roy DoumaniDirector | 50,000 | $1.35 | $67,500 | 75,065 | — | plan? |
| Mar 1, 2017 SForm 4 → | Mar 2, 6:06 am EST | Roy DoumaniDirector | 18,800 | $74.46 | $1,399,815 | 25,065 | −42.9% | plan? |
| Feb 28, 2017 SForm 4 → | Mar 2, 6:05 am EST | Helen Susan KimEVP, Business Development | 50,300 | $67.78 | $3,409,411 | 18,664 | −72.9% | plan? |
| Feb 28, 2017 MForm 4 → | Mar 2, 6:05 am EST | Helen Susan KimEVP, Business Development | 50,300 | $52.35 | $2,633,116 | 21,064 | — | plan? |
| Feb 27, 2017 SForm 4 → | Mar 1, 9:59 pm EST | Cynthia M ButittaChief Operating Officer | 38,882 | $73.46 | $2,856,182 | 117,795 | −24.8% | plan? |
| Feb 27, 2017 MForm 4 → | Mar 1, 9:59 pm EST | Cynthia M ButittaChief Operating Officer | 38,882 | $1.35 | $52,491 | 146,677 | — | plan? |
| Feb 1, 2017 SForm 4 → | Feb 6, 4:36 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | $51.21 | $76,820 | 20,695 | −6.76% | plan? late |
| Feb 1, 2017 MForm 4 → | Feb 6, 4:36 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | $6.89 | $10,335 | 22,195 | — | plan? late |
| Jan 31, 2017 SForm 4 → | Feb 1, 7:09 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | $50.56 | $505,562 | 117,795 | −7.83% | plan? |
| Jan 31, 2017 MForm 4 → | Feb 1, 7:09 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | $1.35 | $13,500 | 127,795 | — | plan? |
| Jan 6, 2017 SForm 4 → | Jan 10, 5:04 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | $50.00 | $75,000 | 20,695 | −6.76% | plan? |
| Jan 6, 2017 MForm 4 → | Jan 10, 5:04 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | $6.89 | $10,335 | 22,195 | — | plan? |
| Jan 6, 2017 SForm 4 → | Jan 10, 5:03 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | $50.13 | $501,289 | 117,795 | −7.83% | plan? |
| Jan 6, 2017 MForm 4 → | Jan 10, 5:03 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | $1.35 | $13,500 | 127,795 | — | plan? |
| Jan 3, 2017 AForm 4 → | Jan 5, 4:56 pm EST | Ian T ClarkDirector | 4,690 | — | — | 4,690 | — | plan? |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:37 pm EST | Shawn TomaselloChief Commercial Officer | 10,600 | — | — | 60,235 | — | plan? |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:36 pm EST | Timothy L. MooreEVP, Technical Operations | 8,400 | — | — | 58,400 | — | plan? |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:34 pm EST | Jeffrey WiezorekSVP Clinical Development | 5,600 | — | — | 20,695 | — | plan? |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:33 pm EST | Paul L JenkinsonChief Financial Officer | 6,600 | — | — | 6,600 | — | plan? |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:29 pm EST | Helen Susan KimEVP, Business Development | 10,600 | — | — | 18,664 | — | plan? |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:28 pm EST | David D ChangEVP, R&D, Chief Medical Off. | 24,800 | — | — | 49,923 | — | plan? |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:21 pm EST | Cynthia M ButittaChief Operating Officer | 24,800 | — | — | 117,795 | — | plan? |
| Dec 20, 2016 SForm 4 → | Dec 22, 4:53 pm EST | Jeffrey WiezorekSVP Clinical Development | 716 | $50.86 | $36,416 | 15,095 | −4.53% | plan? |
| Dec 20, 2016 SForm 4 → | Dec 22, 4:52 pm EST | Shawn TomaselloChief Commercial Officer | 4,901 | $50.86 | $249,265 | 49,635 | −8.99% | plan? |
| Dec 20, 2016 SForm 4 → | Dec 22, 4:51 pm EST | Helen Susan KimEVP, Business Development | 936 | $50.86 | $47,605 | 8,064 | −10.4% | plan? |
| Dec 20, 2016 SForm 4 → | Dec 22, 4:50 pm EST | David D ChangEVP, R&D, Chief Medical Off. | 1,788 | $50.86 | $90,938 | 25,123 | −6.64% | plan? |
| Dec 20, 2016 SForm 4 → | Dec 22, 4:48 pm EST | Cynthia M ButittaChief Operating Officer | 2,482 | $50.86 | $126,235 | 92,995 | −2.60% | plan? |
| Dec 20, 2016 SForm 4 → | Dec 22, 4:47 pm EST | Arie BelldegrunChairman, President and CEO, Director | 3,493 | $50.86 | $177,654 | 24,707 | −12.4% | plan? |
| Dec 9, 2016 AGForm 4 → | Dec 29, 5:50 pm EST | Arie BelldegrunChairman, President and CEO, Director | 109,800 | — | — | 68,507 | — | plan? late |
| Dec 1, 2016 SForm 4 → | Dec 5, 7:03 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | $50.76 | $76,134 | 15,811 | −8.67% | plan? |
| Dec 1, 2016 MForm 4 → | Dec 5, 7:03 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | $6.89 | $10,335 | 17,311 | — | plan? |
| Nov 25, 2016 SForm 4 → | Nov 29, 5:02 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | $50.40 | $504,015 | 95,477 | −9.48% | plan? |
| Nov 25, 2016 MForm 4 → | Nov 29, 5:02 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | $1.35 | $13,500 | 105,477 | — | plan? |
| Nov 10, 2016 SForm 4 → | Nov 14, 6:57 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | $50.65 | $506,467 | 95,477 | −9.48% | plan? |
| Nov 10, 2016 MForm 4 → | Nov 14, 6:57 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | $1.35 | $13,500 | 105,477 | — | plan? |
| Nov 10, 2016 SForm 4 → | Nov 14, 6:55 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | $50.18 | $75,270 | 15,811 | −8.67% | plan? |
| Nov 10, 2016 MForm 4 → | Nov 14, 6:55 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | $6.89 | $10,335 | 17,311 | — | plan? |
| Oct 3, 2016 SForm 4 → | Oct 5, 7:44 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | $54.81 | $82,214 | 15,811 | −8.67% | plan? |
| Oct 3, 2016 MForm 4 → | Oct 5, 7:44 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | $6.89 | $10,335 | 17,311 | — | plan? |
| Sep 28, 2016 GForm 5 → | Feb 14, 2017, 6:17 pm EST | Joshua A KazamDirector | 215,000 | — | — | 1,950 | — | plan? |
| Sep 26, 2016 SForm 4 → | Sep 28, 5:03 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $54.13 | $541,300 | 95,477 | −9.48% | plan? |
| Sep 26, 2016 MForm 4 → | Sep 28, 5:03 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $1.35 | $13,500 | 105,477 | — | plan? |
| Sep 1, 2016 SForm 4 → | Sep 2, 6:34 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | $58.24 | $87,362 | 15,811 | −8.67% | plan? |
| Sep 1, 2016 MForm 4 → | Sep 2, 6:34 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | $6.89 | $10,335 | 17,311 | — | plan? |
| Aug 25, 2016 SForm 4 → | Aug 26, 6:38 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $58.28 | $582,775 | 95,477 | −9.48% | plan? |
| Aug 25, 2016 MForm 4 → | Aug 26, 6:38 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $1.35 | $13,500 | 105,477 | — | plan? |
| Aug 12, 2016 SForm 4 → | Aug 16, 8:16 pm EDT | Helen Susan KimEVP, Business Development | 35,900 | $60.27 | $2,163,825 | 9,000 | −80.0% | plan? |
| Aug 12, 2016 MForm 4 → | Aug 16, 8:16 pm EDT | Helen Susan KimEVP, Business Development | 35,900 | $51.43 | $1,846,337 | 11,400 | — | plan? |
| Aug 1, 2016 SForm 4 → | Aug 2, 6:51 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | $56.90 | $85,343 | 14,867 | −9.16% | plan? |
| Aug 1, 2016 MForm 4 → | Aug 2, 6:51 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | $6.89 | $10,335 | 16,367 | — | plan? |
| Jul 25, 2016 SForm 4 → | Jul 26, 7:03 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $50.94 | $509,350 | 95,401 | −9.49% | plan? |
| Jul 25, 2016 MForm 4 → | Jul 26, 7:03 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $1.35 | $13,500 | 105,401 | — | plan? |
| Jul 1, 2016 SForm 4 → | Jul 5, 6:27 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | $50.00 | $75,007 | 14,867 | −9.16% | plan? |
| Jul 1, 2016 MForm 4 → | Jul 5, 6:27 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | $6.89 | $10,335 | 16,367 | — | plan? |
| Jun 23, 2016 SForm 4 → | Jun 27, 7:08 pm EDT | Cynthia M ButittaChief Operating Officer | 20,000 | $50.71 | $1,014,238 | 95,401 | −17.3% | plan? |
| Jun 23, 2016 MForm 4 → | Jun 27, 7:08 pm EDT | Cynthia M ButittaChief Operating Officer | 20,000 | $1.35 | $27,000 | 105,401 | — | plan? |
| Jun 6, 2016 SForm 4 → | Jun 8, 7:27 pm EDT | Roy DoumaniDirector | 14,000 | $58.04 | $812,581 | 27,865 | −33.4% | plan? |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:20 pm EDT | Farah ChampsiDirector | 1,950 | — | — | 21,616 | — | plan? |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:15 pm EDT | Franz B HumerDirector | 1,950 | — | — | 4,021 | — | plan? |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:15 pm EDT | Jonathan M PeacockDirector | 1,950 | — | — | 67,964 | — | plan? |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:14 pm EDT | Roy DoumaniDirector | 1,950 | — | — | 141,017 | — | plan? |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:13 pm EDT | Ran NussbaumDirector | 1,950 | — | — | 1,950 | — | plan? |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:12 pm EDT | Joshua A KazamDirector | 1,950 | — | — | 216,950 | — | plan? |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:11 pm EDT | David BondermanDirector | 1,950 | — | — | 1,950 | — | plan? |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:10 pm EDT | Steven B RuchefskyDirector | 1,950 | — | — | 87,988 | — | plan? |
| May 31, 2016 SForm 4 → | Jun 2, 5:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 3,000 | $50.65 | $151,949 | 14,867 | −16.8% | plan? |
| May 31, 2016 MForm 4 → | Jun 2, 5:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 3,000 | $6.89 | $20,670 | 16,367 | — | plan? |
| Apr 4, 2016 SForm 4 → | Apr 6, 7:06 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | $50.00 | $500,000 | 95,401 | −9.49% | plan? |
| Apr 4, 2016 MForm 4 → | Apr 6, 7:06 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | $1.35 | $13,500 | 105,401 | — | plan? |
| Mar 15, 2016 SForm 4 → | Mar 17, 9:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 9,000 | $44.88 | $403,943 | 14,867 | −37.7% | plan? |
| Mar 15, 2016 MForm 4 → | Mar 17, 9:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 9,000 | $6.89 | $62,010 | 23,867 | — | plan? |
| Mar 15, 2016 SForm 4 → | Mar 17, 9:15 pm EDT | Rizwana F SprouleVP Regulatory Affairs | 8,500 | $45.27 | $384,791 | 10,211 | −45.4% | plan? |
| Mar 15, 2016 MForm 4 → | Mar 17, 9:15 pm EDT | Rizwana F SprouleVP Regulatory Affairs | 8,500 | $1.35 | $11,475 | 18,711 | — | plan? |
| Mar 15, 2016 SForm 4 → | Mar 17, 9:14 pm EDT | Margo R RobertsChief Scientific Officer | 8,506 | $45.23 | $384,766 | 10,655 | −44.4% | plan? |
| Mar 15, 2016 MForm 4 → | Mar 17, 9:14 pm EDT | Margo R RobertsChief Scientific Officer | 8,506 | $2.63 | $22,352 | 19,161 | — | plan? |
| Mar 15, 2016 AForm 4 → | Mar 16, 8:16 pm EDT | Timothy L. MooreEVP, Technical Operations | 50,000 | — | — | 50,000 | — | plan? |
| Mar 10, 2016 AForm 4 → | Mar 24, 6:56 pm EDT | Franz B HumerDirector | 2,071 | — | — | 2,071 | — | plan? late |
| Mar 1, 2016 SForm 4 → | Mar 3, 7:13 pm EST | Cynthia M ButittaCOO and CFO | 10,000 | $50.03 | $500,300 | 95,401 | −9.49% | plan? |
| Mar 1, 2016 MForm 4 → | Mar 3, 7:13 pm EST | Cynthia M ButittaCOO and CFO | 10,000 | $1.35 | $13,500 | 105,401 | — | plan? |
| Feb 17, 2016 MForm 4/A → | Mar 17, 9:13 pm EDT | Margo R RobertsChief Scientific Officer | 9,632 | $2.40 | $23,157 | 18,730 | — | plan? |
| Feb 17, 2016 SForm 4 → | Feb 19, 4:14 pm EST | Margo R RobertsChief Scientific Officer | 9,632 | $45.06 | $434,018 | 9,098 | −51.4% | plan? amended |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:14 pm EST | Margo R RobertsChief Scientific Officer | 9,632 | $0.70 | $6,742 | 18,730 | — | plan? amended |
| Feb 17, 2016 SForm 4 → | Feb 19, 4:13 pm EST | Rizwana F SprouleVP Regulatory Affairs | 9,567 | $45.08 | $431,279 | 8,741 | −52.3% | plan? |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:13 pm EST | Rizwana F SprouleVP Regulatory Affairs | 9,567 | $1.35 | $12,915 | 18,308 | — | plan? |
| Feb 16, 2016 SForm 4 → | Feb 18, 8:34 pm EST | Jeffrey WiezorekSVP Clinical Development | 9,000 | $44.07 | $396,652 | 13,742 | −39.6% | plan? |
| Feb 16, 2016 MForm 4 → | Feb 18, 8:34 pm EST | Jeffrey WiezorekSVP Clinical Development | 9,000 | $6.89 | $62,010 | 22,742 | — | plan? |
| Feb 12, 2016 SForm 4 → | Feb 16, 7:05 pm EST | Margo R RobertsChief Scientific Officer | 18,750 | $64.16 | $1,202,964 | 9,098 | −67.3% | plan? |
| Feb 12, 2016 MForm 4 → | Feb 16, 7:05 pm EST | Margo R RobertsChief Scientific Officer | 18,750 | $0.70 | $13,125 | 27,848 | — | plan? |
| Feb 2, 2016 SForm 4 → | Feb 4, 9:06 pm EST | Cynthia M ButittaCOO and CFO | 1,900 | $50.13 | $95,247 | 94,007 | −1.98% | plan? |
| Feb 2, 2016 MForm 4 → | Feb 4, 9:06 pm EST | Cynthia M ButittaCOO and CFO | 1,900 | $1.35 | $2,565 | 95,907 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 3, 7:04 pm EST | Marc BetterVP, Product Sciences | 9,000 | $47.34 | $426,036 | 7,688 | −53.9% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 3, 7:04 pm EST | Marc BetterVP, Product Sciences | 9,000 | $0.38 | $3,420 | 16,688 | — | plan? |
| Jan 27, 2016 SForm 4 → | Jan 29, 6:15 pm EST | Cynthia M ButittaCOO and CFO | 8,100 | $51.62 | $418,128 | 94,007 | −7.93% | plan? |
| Jan 27, 2016 MForm 4 → | Jan 29, 6:15 pm EST | Cynthia M ButittaCOO and CFO | 8,100 | $1.35 | $10,935 | 102,107 | — | plan? |
| Jan 15, 2016 SForm 4 → | Jan 19, 8:24 pm EST | Jeffrey WiezorekSVP Clinical Development | 9,000 | $55.26 | $497,379 | 13,742 | −39.6% | plan? |
| Jan 15, 2016 MForm 4 → | Jan 19, 8:24 pm EST | Jeffrey WiezorekSVP Clinical Development | 9,000 | $6.89 | $62,010 | 22,742 | — | plan? |
| Jan 15, 2016 SForm 4 → | Jan 19, 8:23 pm EST | Rizwana F SprouleVP Regulatory Affairs | 9,567 | $55.49 | $530,831 | 8,741 | −52.3% | plan? |
| Jan 15, 2016 MForm 4 → | Jan 19, 8:23 pm EST | Rizwana F SprouleVP Regulatory Affairs | 9,567 | $1.35 | $12,915 | 11,508 | — | plan? |
| Jan 15, 2016 SForm 4 → | Jan 19, 8:22 pm EST | Margo R RobertsChief Scientific Officer | 6,145 | $55.22 | $339,323 | 9,098 | −40.3% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2016 MForm 4 → | Feb 3, 7:04 pm EST | Marc BetterVP, Product Sciences | 9,000 | — | — | 60,000 | — | |
| Jan 27, 2016 MForm 4 → | Jan 29, 6:15 pm EST | Cynthia M ButittaCOO and CFO | 8,100 | — | — | 327,294 | — | |
| Jan 15, 2016 MForm 4 → | Jan 19, 8:24 pm EST | Jeffrey WiezorekSVP Clinical Development | 9,000 | — | — | 94,000 | — | |
| Jan 15, 2016 MForm 4 → | Jan 19, 8:23 pm EST | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 113,897 | — | |
| Jan 15, 2016 MForm 4 → | Jan 19, 8:22 pm EST | Margo R RobertsChief Scientific Officer | 6,145 | — | — | 32,588 | — | |
| Jan 4, 2016 MForm 4 → | Jan 5, 7:45 pm EST | Marc BetterVP, Product Sciences | 9,000 | — | — | 69,000 | — | |
| Dec 28, 2015 MForm 4 → | Dec 29, 7:17 pm EST | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 335,394 | — | |
| Dec 17, 2015 AForm 4 → | Dec 21, 8:42 pm EST | Shawn TomaselloChief Commercial Officer | 160,000 | — | — | 160,000 | — | |
| Dec 17, 2015 AForm 4 → | Dec 21, 8:40 pm EST | Marc BetterVP, Product Sciences | 8,800 | — | — | 8,800 | — | |
| Dec 17, 2015 AForm 4 → | Dec 21, 8:39 pm EST | Rizwana F SprouleVP Regulatory Affairs | 8,800 | — | — | 8,800 | — | |
| Dec 17, 2015 AForm 4 → | Dec 21, 8:38 pm EST | Margo R RobertsChief Scientific Officer | 24,800 | — | — | 24,800 | — | |
| Dec 17, 2015 AForm 4 → | Dec 21, 8:37 pm EST | Jeffrey WiezorekSVP Clinical Development | 26,400 | — | — | 26,400 | — | |
| Dec 17, 2015 AForm 4 → | Dec 21, 8:36 pm EST | Helen Susan KimEVP, Business Development | 33,000 | — | — | 33,000 | — | |
| Dec 17, 2015 AForm 4 → | Dec 21, 8:36 pm EST | David D ChangEVP, R&D, Chief Medical Off. | 66,100 | — | — | 66,100 | — | |
| Dec 17, 2015 AForm 4 → | Dec 21, 8:35 pm EST | Cynthia M ButittaCOO and CFO | 66,100 | — | — | 66,100 | — | |
| Dec 17, 2015 AForm 4 → | Dec 21, 8:34 pm EST | Arie BelldegrunChairman, President and CEO, Director, 10% Owner | 100,700 | — | — | 100,700 | — | |
| Dec 15, 2015 MForm 4 → | Dec 17, 7:33 pm EST | Jeffrey WiezorekSVP Clinical Development | 9,000 | — | — | 103,000 | — | |
| Dec 15, 2015 MForm 4 → | Dec 17, 7:33 pm EST | Margo R RobertsChief Scientific Officer | 6,145 | — | — | 33,233 | — | |
| Dec 15, 2015 MForm 4 → | Dec 17, 7:32 pm EST | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 123,464 | — | |
| Dec 1, 2015 MForm 4 → | Dec 3, 6:53 pm EST | Marc BetterVP, Product Sciences | 9,000 | — | — | 78,000 | — | |
| Nov 30, 2015 AMForm 4 → | Feb 18, 2016, 8:34 pm EST | Jeffrey WiezorekSVP Clinical Development | 34,000 | — | — | 16,000 | — | late |
| Nov 27, 2015 MForm 4 → | Nov 30, 8:23 pm EST | Cynthia M ButittaCOO and CFO | 15,000 | — | — | 345,394 | — | |
| Nov 16, 2015 MForm 4 → | Nov 18, 7:32 pm EST | Margo R RobertsChief Scientific Officer | 6,145 | — | — | 33,878 | — | |
| Nov 16, 2015 MForm 4 → | Nov 18, 7:31 pm EST | Jeffrey WiezorekSVP Clinical Development | 9,000 | — | — | 112,000 | — | |
| Nov 16, 2015 MForm 4 → | Nov 18, 7:29 pm EST | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 133,031 | — | |
| Nov 10, 2015 MForm 4 → | Nov 12, 6:33 pm EST | Cynthia M ButittaCOO and CFO | 5,000 | — | — | 360,394 | — | |
| Nov 10, 2015 MForm 4 → | Nov 12, 6:32 pm EST | David D ChangEVP, R&D, Chief Medical Off. | 30,800 | — | — | 223,000 | — | |
| Nov 2, 2015 MForm 4 → | Nov 4, 7:06 pm EST | Marc BetterVP, Product Sciences | 9,000 | — | — | 87,000 | — | |
| Nov 2, 2015 MForm 4 → | Nov 4, 7:05 pm EST | David D ChangEVP, R&D, Chief Medical Off. | 7,700 | — | — | 253,800 | — | |
| Oct 27, 2015 MForm 4 → | Oct 28, 7:17 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 365,394 | — | |
| Oct 15, 2015 MForm 4 → | Oct 19, 7:30 pm EDT | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 142,598 | — | |
| Oct 15, 2015 MForm 4 → | Oct 19, 7:29 pm EDT | Jeffrey WiezorekSVP Clinical Development | 9,000 | — | — | 121,000 | — | |
| Oct 15, 2015 MForm 4 → | Oct 19, 7:28 pm EDT | Margo R RobertsChief Scientific Officer | 6,145 | — | — | 34,523 | — | |
| Oct 1, 2015 MForm 4 → | Oct 2, 7:19 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 7,700 | — | — | 261,500 | — | |
| Oct 1, 2015 MForm 4 → | Oct 2, 7:18 pm EDT | Marc BetterVP, Product Sciences | 9,000 | — | — | 96,000 | — | |
| Sep 28, 2015 MForm 4 → | Sep 30, 7:01 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 375,394 | — | |
| Sep 15, 2015 MForm 4 → | Sep 17, 8:01 pm EDT | Jeffrey WiezorekVP Clinical Development | 9,000 | — | — | 130,000 | — | |
| Sep 15, 2015 MForm 4 → | Sep 17, 8:00 pm EDT | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 152,165 | — | |
| Sep 15, 2015 MForm 4 → | Sep 17, 7:59 pm EDT | Margo R RobertsChief Scientific Officer | 6,145 | — | — | 35,168 | — | |
| Sep 9, 2015 AForm 4 → | Sep 17, 1:48 pm EDT | Franz B HumerDirector | 20,000 | — | — | 20,000 | — | late |
| Sep 3, 2015 MForm 4 → | Sep 8, 7:14 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 7,700 | — | — | 269,200 | — | |
| Sep 1, 2015 MForm 4 → | Sep 3, 7:07 pm EDT | Marc BetterVP, Product Sciences | 9,000 | — | — | 105,000 | — | |
| Aug 27, 2015 MForm 4 → | Aug 28, 7:07 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 385,394 | — | |
| Aug 17, 2015 MForm 4 → | Aug 19, 8:04 pm EDT | Jeffrey WiezorekVP Clinical Development | 9,000 | — | — | 139,000 | — | |
| Aug 17, 2015 MForm 4 → | Aug 19, 8:03 pm EDT | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 161,732 | — | |
| Aug 17, 2015 MForm 4 → | Aug 19, 8:01 pm EDT | Margo R RobertsChief Scientific Officer | 6,145 | — | — | 35,813 | — | |
| Aug 3, 2015 MForm 4 → | Aug 4, 7:30 pm EDT | Marc BetterVP, Product Sciences | 9,000 | — | — | 114,000 | — | |
| Aug 3, 2015 MForm 4 → | Aug 4, 7:29 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 7,700 | — | — | 276,900 | — | |
| Jul 27, 2015 MForm 4 → | Jul 28, 7:03 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 395,394 | — | |
| Jul 15, 2015 MForm 4 → | Jul 23, 2:29 pm EDT | Margo R RobertsChief Scientific Officer | 22,167 | — | — | 36,458 | — | late |
| Jul 15, 2015 MForm 4 → | Jul 20, 9:03 pm EDT | Jeffrey WiezorekVP Clinical Development | 9,000 | — | — | 148,000 | — | late |
| Jul 15, 2015 MForm 4 → | Jul 20, 9:02 pm EDT | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 171,299 | — | late |
| Jul 1, 2015 MForm 4 → | Jul 2, 8:36 pm EDT | Marc BetterVP, Product Sciences | 9,000 | — | — | 123,000 | — | |
| Jul 1, 2015 MForm 4 → | Jul 2, 8:35 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 7,700 | — | — | 284,600 | — | |
| Jun 29, 2015 MForm 4 → | Jul 1, 7:15 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 405,394 | — | |
| Jun 15, 2015 MForm 4 → | Jun 17, 7:19 pm EDT | Jeffrey WiezorekVP Clinical Development | 9,000 | — | — | 157,000 | — | |
| Jun 15, 2015 MForm 4 → | Jun 17, 7:17 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 7,700 | — | — | 292,300 | — | |
| Jun 15, 2015 MForm 4 → | Jun 17, 7:16 pm EDT | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 180,866 | — | |
| Jun 15, 2015 MForm 4 → | Jun 17, 7:15 pm EDT | Margo R RobertsChief Scientific Officer | 8,625 | — | — | 132,750 | — | |
| Jun 9, 2015 AForm 4 → | Jun 17, 7:13 pm EDT | Roy DoumaniDirector | 10,000 | — | — | 10,000 | — | late |
| Jun 9, 2015 AForm 4 → | Jun 17, 7:11 pm EDT | Steven B RuchefskyDirector | 10,000 | — | — | 10,000 | — | late |
| Jun 9, 2015 AForm 4 → | Jun 17, 7:09 pm EDT | Jonathan M PeacockDirector | 10,000 | — | — | 10,000 | — | late |
| Jun 9, 2015 AForm 4 → | Jun 17, 7:08 pm EDT | Ran NussbaumDirector | 10,000 | — | — | 10,000 | — | late |
| Jun 9, 2015 AForm 4 → | Jun 17, 7:07 pm EDT | Joshua A KazamDirector | 10,000 | — | — | 10,000 | — | late |
| Jun 9, 2015 AForm 4 → | Jun 17, 7:04 pm EDT | Farah ChampsiDirector | 10,000 | — | — | 10,000 | — | late |
| Jun 9, 2015 AForm 4 → | Jun 17, 7:03 pm EDT | David BondermanDirector | 10,000 | — | — | 10,000 | — | late |
| Jun 1, 2015 MForm 4 → | Jun 3, 7:38 pm EDT | Marc BetterVP, Product Sciences | 9,000 | — | — | 132,000 | — | |
| May 27, 2015 MForm 4 → | May 29, 6:56 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 415,394 | — | |
| May 19, 2015 AMForm 4 → | Aug 16, 2016, 8:16 pm EDT | Helen Susan KimEVP, Business Development | 155,900 | — | — | 84,100 | — | late |
| May 15, 2015 MForm 4 → | May 19, 8:02 pm EDT | Margo R RobertsChief Scientific Officer | 8,625 | — | — | 141,375 | — | |
| May 15, 2015 MForm 4 → | May 19, 8:01 pm EDT | Jeffrey WiezorekVP Clinical Development | 9,000 | — | — | 166,000 | — | |
| May 15, 2015 MForm 4 → | May 19, 8:00 pm EDT | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 190,433 | — | |
| May 1, 2015 MForm 4 → | May 5, 8:28 pm EDT | Marc BetterVP, Product Sciences | 9,000 | — | — | 141,000 | — | |
| Apr 27, 2015 MForm 4/A → | Apr 29, 9:54 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 425,394 | — |